Retirement Investing: Buying Pfizer For A 4.7% Dividend

Welcome to the Discounted Pfizer issue of M&A Daily
Pfizer
159-year-old Pfizer had some problems keeping its dividend up during the stress of the financial crisis, but it has since recovered.
Today, the dividend yield is over 4%. However, starting in 2017, you can get the same dividend at a yield closer to 5% by buying Allergan (AGN) today or by trading out existing Pfizer (PFE) exposure into AGN.

The $41.27 net arbitrage spread is larger than warranted by deal risk. If the deal closes by year-end as expected, it is worth an 18% annual return. You will get 11.3 shares of PFE. Based on today’s market price, that costs just over $25 per PFE share ($25.38 as of this writing) for an even more generous yield.
One potential deal risk is that Democrats in the House of Representatives are trying to push legislation to keep businesses from escaping the high US corporate tax via inversions. The new legislation would reduce or remove the financial thresholds that allow companies to pursue the earnings-stripping after an inversion. However, this is not legislation likely to make progress in a Republican-controlled House. While both the White House and Senate are up in the air, it is unlikely that the House will change hands before the next census.
Yahoo
Yahoo (YHOO) shareholder Canyon Capital sent a letter to the company’s board urging them to move ahead with the auction of its core business.
Williams
Williams (WMB) will put its Canadian... Read more